BioSpace News Archive

Last week, KC area native Erin Smith was named to the 2019 Forbes 30 Under 30 Healthcare list.

State-of-the-Art Cancer Treatment Center Named in Honor of U.S. Senator Orrin G. Hatch

16-Year-Old Cancer Patient Raises $5,000 for Jacob’s Heart

The U.S. Food and Drug Administration today posted warning letters issued to two companies for the illegal marketing of products labeled as dietary supplements that contain tianeptine, a chemical compound that companies are illegally claiming treats opioid use disorder (OUD), pain and anxiety, and other unlawful and unproven claims.

Heron Therapeutics, Inc. announced that Barry D. Quart, Pharm.D., Chief Executive Officer of Heron Therapeutics, will participate in a fireside chat at the Evercore ISI HealthCONx Conference on Tuesday, November 27, 2018, at 10:15 a.m. EST at the Boston Harbor Hotel.

Synlogic announced today that Aoife Brennan, M.B., B.Ch., Synlogic’s president and chief executive officer, will provide a corporate update at the 30th Annual Piper Jaffray Healthcare Conference at 8:30 am ET on Wednesday, November 28, 2018, in New York City.

Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced it has received ISO (International Standards Organization) 27001 certification of its Omnipod DASH™ System.

Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, today announced that Aron Knickerbocker, Chief Executive Officer, will present at the 30th Annual Piper Jaffray Healthcare Conference, November 28, 2018

Kewaunee Scientific Corporation (Nasdaq: KEQU) today announced that the Company plans to release its second quarter fiscal year 2019 financial results on Tuesday, December 4, 2018 after the close of trading.

Streamline Health Solutions, Inc. today announced it extended its banking agreement with Wells Fargo into its fiscal year 2020. The original agreement with Wells Fargo was to expire in November of 2019.